
|Articles|July 1, 2007
Lightening up: Other options
National report - With no indication when the Food and Drug Administration (FDA) will decide on its proposed rule essentially banning all hydroquinone products that have not undergone the new drug approval process, dermatologists and patients are seeking alternatives.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Digital Twins in Dermatology: Your Patient’s Virtual Double Is Coming
2
Social Media Mythbusters: Skin Cycling
3
Quality of Life in CSU Shaped by More Than Skin Symptoms
4
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
5














